Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats.

Thrice daily transdermal LEV resulted in median serum concentrations ≥5 μg/mL throughout the sampling period and clinical adverse events were minimal. Transdermal LEV can provide an alternative for cats resistant to administration of other forms of anticonvulsant medication.